KF
FCSC

Krilogy Financial’s Fibrocell Science Inc. FCSC Stock Holding History

Krilogy Financial’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-40
Closed – – 796
2018
Q3 		$0 Buy
+40
New +$86 ﹤0.01% 851
2018
Q2 		– Sell
-40
Closed – – 716
2018
Q1 		$0 Hold
40
– – ﹤0.01% 833
2017
Q4 		$0 Hold
40
– – ﹤0.01% 868
2017
Q3 		$1K Buy
40
+7
+21% +$113 ﹤0.01% 793
2017
Q2 		$1K Sell
33
-67
-67% -$827 ﹤0.01% 709
2017
Q1 		$0 Buy
100
+67
+203% +$743 ﹤0.01% 731
2016
Q4 		$0 Hold
33
– – ﹤0.01% 781
2016
Q3 		$0 Hold
33
– – ﹤0.01% 796
2016
Q2 		$1K Hold
33
– – ﹤0.01% 736
2016
Q1 		$1K Hold
33
– – ﹤0.01% 670
2015
Q4 		$2K Hold
33
– – ﹤0.01% 390
2015
Q3 		$2K Buy
+33
New +$2.92K ﹤0.01% 560

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Krilogy Financial's FCSC Position: Q4 2018 in Review

Krilogy Financial sold out of Fibrocell Science Inc. (FCSC) in Q4 2018, closing a stake of 40 shares.

Krilogy Financial first reported a position in FCSC in Q3 2015 and held it in 12 quarters. The position peaked at $2K in Q4 2015. 26 funds tracked by Wall St. Rank hold FCSC as of Q4 2018.

  • Krilogy Financial reported no remaining Fibrocell Science Inc. position as of Q4 2018 after selling out during the quarter.
  • Krilogy Financial sold 40 Fibrocell Science Inc. shares in Q4 2018.
  • Krilogy Financial first reported a position in Fibrocell Science Inc. in Q3 2015 and held it in 12 quarters.
  • Krilogy Financial's Fibrocell Science Inc. position peaked at $2K in Q4 2015.
  • 26 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2018.

Based on Krilogy Financial's 13F filing for Q4 2018, filed 14 Feb 2019.